How do you benchmark sequencing accuracy without the benchmark itself being biased? 🤔 A new preprint develops donor-specific assemblies, built with zero short-read bias, to benchmark 9 platforms head-to-head 🧬. See how AVITI™ achieved the lowest error rate of any platform: https://bit.ly/3SfBaQP.

Excited to be at the Cancer Genomics Consortium Annual Meeting in Houston this week 🧬 Stop by our booth to see how Element is rethinking targeted sequencing with Trinity™ on-flow cell hybrid capture on AVITI24™.🔬 #Genomics #AVITI24

⏱️ Turnaround time can be a bottleneck in sequencing workflows for clinical research. Learn now AVITI24™ + Trinity™ can complete target enrichment workflows in as little as one day. Download the guide: https://bit.ly/3PHkLD8. #AVITI24 #ClinicalResearch #NextGenSequencing

That's a wrap on ADLM! 🧬 Thanks to everyone who stopped by to see the AVITI24™ in person and learn how we're pairing it with SOPHiA DDM analysis for a true end-to-end clinical research workflow. Great time connecting with SOPHiA Genetics and the community! #ADLM2026 #AVITI24 #ClinicalResearch

High accuracy at lower costs can open the door to bigger scientific risks. 🧬 Peter Lansdorp shares how outsourcing Strand-seq first introduced their lab to AVITI™, and how becoming an early adopter helped them pursue higher-reward experiments. 🔬 Explore more of their story: https://bit.ly/4v0Ulfv.

🎯 Sequencing data quality can be complicated by PCR-based amplification. With ABC™ sequencing, rolling circle amplification copies the template. See how you can get a chemistry designed to limit noise buildup cycle after cycle in our infographic: https://bit.ly/4fBm7bS. #AVITI #AVITI24 #Sequencing

Wrapped up a great week at AACR D3 🔬 Thanks to everyone who stopped by to chat about seeing more biology behind every assay — great conversations all around. #AVITI24 #Multiomics #DrugDiscovery

Proud to share Element was named one of San Diego's 100 Business Impact Award honorees, hosted by the San Diego Regional EDC and JP Morgan Chase! Thank you for celebrating the innovation driving our region forward. #BiotechInnovation #NextGenSequencing #Multiomics

Meet Jason Bruce, Lab Manager at Element. "It's not enough to just do good work, we have to build processes that let us deliver that quality to customers consistently, at scale." Quality isn't a checkbox here; it's the foundation for how we grow. Join us: https://bit.ly/3OQGOXT.

How do you evaluate NGS platforms for minimal residual disease research? It comes down to error rate, sequencing depth, and cost-per-sample. 🔬 Lower error in difficult regions means you can sequence deeper without raising costs. 🧬 We broke it down in our latest blog: https://bit.ly/44F2kU3.

The right platform doesn't just improve your data; it opens experiments you couldn't run before. 🧬 That's what Anja Mezger, NGI at SciLifeLab, found after using AVITI24™. From high data quality to how they’re approaching multiomics, read our conversation: https://bit.ly/4ysM5H7.

More great stories from WCGALP 🐄🐕 Frances Chen on genotyping pipelines for working dog breeders, Jesse Hoff of Grimmius Cattle on bringing genotyping in-house, and our own Justin Kos leading a workshop on moving from microarrays to AVITI™. Great conversations all around! 🧬 #WCGALP2026 #Sequencing

Ever wonder how ABC™ sequencing actually works? 🧬 We laid out the full cycle, how it stacks up against other chemistries, and why it matters—all in one visual breakdown. Download it today: https://bit.ly/3T4tsJw. #AVITI #AVITI24 #Sequencing

Quality is more than a checkbox. Hear from Devleena Kole and Matt Byrne of Element's Quality team on what it takes to build ISO 13485-certified life science technology in-house in San Diego. Because quality doesn't belong to one team, it belongs to everyone at Element. #BiotechInnovation #AVITI24

The Regional Court of Munich I has ruled that Illumina infringes patent rights controlled by Element. The judgment covers at least MiSeq and MiSeqDx. Illumina cannot supply these products in Germany and must recall systems and kits put into circulation since March 31, 2023. https://bit.ly/4ymw1qe

Looking back on a great week in Osaka 🇯🇵 at JSOT with our partner Kiko Tech — showcasing AVITI24™ and a lunch seminar on high-precision sequencing & 5D multiomics for toxicology. Thanks to the 150+ attendees for the great conversations! 🧬🙌 #AVITI24 #Toxicology #NextGenSequencing

Every clinical research pipeline has its own needs. That's why AVITI24™ integrates with what labs already have instead of replacing it. ⚙️ See what getting started with AVITI24 looks like in practice. Get the guide: https://bit.ly/3PHkLD8. #AVITI24 #ClinicalResearch #NextGenSequencing

Devleena Kole leads a growing Quality team built on one simple idea: "Quality belongs to everyone at Element: building the frameworks and systems that help everyone consistently deliver their best work." That's how innovation scales. Explore open roles: https://bit.ly/3OQGOXT

New app note with Watchmaker and Aíma: cfDNA methylation profiling on the AVITI™ hit >95% mapping efficiency across breast, colon, and lung cancer samples, with AI-based tumor scores showing strong concordance with long-read sequencing for liquid biopsy applications. 🧬 https://bit.ly/4eSa5vL

🔬 Now on-demand: Tilmann Buerckstuemmer, PhD (CSO, Myllia Biotechnology) on using AVITI24™ for an optical pooled CRISPR screen to uncover NF-κB pathway regulators. CRISPR perturbations, p65 localization, and cell morphology — captured in one automated run. Watch now: https://bit.ly/4w0IOwB.

Great few days at Biology at Scale at the Wellcome Genome Campus talking CRISPR screens, optical pooled screening, and multiomic screening workflows on AVITI24™. 🧬 If you stopped by, thanks for the conversation! #BiologyatScale2026 #CRISPRScreening #Multiomics #AVITI24

⏳ In clinical research, the time between sample and insight matters. 🧬 Trinity™ eliminates manual post-hybridization steps, cuts hybrid capture to five hours, and delivers better coverage and variant calling than traditional workflows. Read how it was designed: https://bit.ly/3QTIMrF. #Sequencing

Element recently sat down with The San Diego Business Journal to discuss our Series E. “ …I think it just shows that the company has good bones, and is here to stay.” - Logan Zinser, CFO of Element Read the full article (paywalled): https://bit.ly/3QI5umx. #NextGenSequencing #Multiomics

Miss the live session? Our recent webinar with Qiagen is now on demand. 🎬 See how we used the QIAseq xHYB Trinity™ hybrid capture workflow for DNA and RNA to streamline CGP applications. Watch it on demand: https://bit.ly/4vniUTn. #Sequencing #HybridCapture

A big thank you to the Human Cell Atlas community for the great conversations at this week's General Meeting in Boston! 🙏🔬 We loved sharing our latest innovations in single-cell analysis & spatial transcriptomics. Learn more about AVITI24: https://bit.ly/4p4rvry! 🚀 #HCA2026 #AVITI24 #Multiomics

Just wrapped the SOPHiA GENETICS 2026 EMEA Innovation Summit in San Sebastián. We are proud to be a partner in driving the future of precision medicine. Pairing our AVITI™ sequencing systems with SOPHiA DDM™ AI analytics is redefining what's possible in NGS. Read more: https://bit.ly/4nNmOks.

We're ISO 13485 certified. 🎉 This isn't just a milestone; it's a validation of the quality Element has always operated at, and a critical step toward our evolution beyond research sequencing. SVP of Operations, Jeff Labbadia, explains what it took and what it unlocks. 🎥 https://bit.ly/4fS3Tos

VIB Spatial Omics is ending and it was a great one! Thank you to everyone who attended our talk or stopped by our booth. 🤝 We hope you’re as excited about the possibilities with Direct In Sample Sequencing on AVITI24™ as we are. #AVITI24 #NextGenSequencing #Multiomics

An optical pooled CRISPR screen on AVITI24™ linked sgRNA identity, p65 localization, and cell morphology in one automated workflow to uncover NF-κB regulators. The webinar with Tilmann Buerckstuemmer, PhD, CSO of Myllia Biotechnology is now available on demand. Watch it: https://bit.ly/4w0IOwB.

Claudia Jamison, VP of Software, has spent 5 years building the team that stitches the fabric our innovations together — from R&D to manufacturing. "When you face adversity with people you trust, and find a way through — that's when you know what you've built." https://bit.ly/3OQGOXT